Drawing for POWERCRIMP

USPTO serial 78231383

POWERCRIMP

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SUAREZ, MARIA VICTORIA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with POWERCRIMP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ann Lamport Hammitte

THOMAS V SMURZYNSKI LAHIVE & COCKFIELD LLPONE POST OFFICE SQBOSTON, MA 02109-2127UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical devices, namely, balloon catheters and stentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 15, 2008MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 15, 2008ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 3, 2007EX5GSOU EXTENSION 5 GRANTED—
Dec 15, 2006EXT5SOU EXTENSION 5 FILED—
Dec 15, 2006MAILPAPER RECEIVED—
Oct 11, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 21, 2006EX4GSOU EXTENSION 4 GRANTED—
Jun 2, 2006EXT4SOU EXTENSION 4 FILED—
Jun 2, 2006MAILPAPER RECEIVED—
Feb 18, 2006EX3GSOU EXTENSION 3 GRANTED—
Jan 26, 2006EXT3SOU EXTENSION 3 FILED—
Jan 26, 2006MAILPAPER RECEIVED—
Aug 30, 2005EX2GSOU EXTENSION 2 GRANTED—
Aug 18, 2005MAILPAPER RECEIVED—
Aug 15, 2005EXT2SOU EXTENSION 2 FILED—
Jun 8, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 14, 2004EX1GSOU EXTENSION 1 GRANTED—
Dec 14, 2004EXT1SOU EXTENSION 1 FILED—
Dec 14, 2004MAILPAPER RECEIVED—
Aug 17, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 25, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 5, 2004NPUBNOTICE OF PUBLICATION—
Mar 16, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 20, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 20, 2004EMRVEMAIL RECEIVED—
Dec 5, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 28, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 27, 2003DOCKASSIGNED TO EXAMINER—
May 16, 2003UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
May 16, 2003MAILPAPER RECEIVED—

Frequently asked questions

Related guidance